Preclinical concept studies showing advantage of an inhaled anti-CTGF/CCN2 protein for pulmonary fibrosis treatment.
临床前概念研究表明吸入抗 CTGF/CCN2 蛋白在治疗肺纤维化方面具有优势
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-58568-x
Neiens Vanessa, Hansbauer Eva-Maria, Jaquin Thomas J, Peper-Gabriel Janet K, Mahavadi Poornima, Snyder Mark E, Grill Maximilian J, Wurzenberger Cornelia, Konitsiotis Antonio, Estrada-Bernal Adriana, Heinig Kristina, Fysikopoulos Athanasios, Schwenck Nicolas, Grüner Stefan, Bartoschek Denis, Mosebach Theresia, Kerstan Sandra, Wrennall Joe, Richter Marleen, Noda Kentaro, Hoetzenecker Konrad, Burgess Janette K, Tarran Robert, Wurzenberger Claudia, Wichmann Karl-Robert, Biehler Jonas, Müller Kei W, Guenther Andreas, Eickelberg Oliver, Fitzgerald Mary F, Olwill Shane A, Matschiner Gabriele, Pavlidou Marina
